{"id":"https://openalex.org/W2323826331","doi":"https://doi.org/10.1158/0008-5472.sabcs-09-6110","title":"A Type I Insulin-Like Growth Factor Receptor Kinase Inhibitor (PQIP) Enhances the Cytotoxicity of Doxorubicin in Human Cancer Cell Lines.","display_name":"A Type I Insulin-Like Growth Factor Receptor Kinase Inhibitor (PQIP) Enhances the Cytotoxicity of Doxorubicin in Human Cancer Cell Lines.","publication_year":2009,"publication_date":"2009-12-01","ids":{"openalex":"https://openalex.org/W2323826331","doi":"https://doi.org/10.1158/0008-5472.sabcs-09-6110","mag":"2323826331"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs-09-6110","doi":"https://doi.org/10.1158/0008-5472.sabcs-09-6110","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs-09-6110","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110689288","display_name":"Xingxing Zeng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X. Zeng","raw_affiliation_strings":["1University of Minnesota, Masonic Cancer Center, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Minnesota, Masonic Cancer Center, MN,","institution_ids":["https://openalex.org/I4390039358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040424020","display_name":"Elizabeth A. Buck","orcid":"https://orcid.org/0000-0002-6022-1871","observed_orcids":["https://orcid.org/0000-0002-6022-1871"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Buck","raw_affiliation_strings":["2OSI Pharmaceuticals, Inc., NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSI Pharmaceuticals, Inc., NY,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033966004","display_name":"Douglas Yee","orcid":"https://orcid.org/0000-0002-3387-4009","observed_orcids":["https://orcid.org/0000-0002-3387-4009"]},"institutions":[{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Yee","raw_affiliation_strings":["1University of Minnesota, Masonic Cancer Center, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Minnesota, Masonic Cancer Center, MN,","institution_ids":["https://openalex.org/I4390039358"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"69","issue":"24_Supplement","first_page":"6110","last_page":"6110"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9100000262260437},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8600000143051147},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6129999756813049},{"id":"https://openalex.org/keywords/insulin-receptor","display_name":"insulin receptor","score":0.503000020980835},{"id":"https://openalex.org/keywords/mitogen-activated-protein-kinase","display_name":"mitogen-activated protein kinase","score":0.8510000109672546},{"id":"https://openalex.org/keywords/phosphatidylinositol-3-kinase","display_name":"phosphatidylinositol 3-kinase","score":0.9919999837875366},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.890999972820282},{"id":"https://openalex.org/keywords/parp-cleavage","display_name":"PARP cleavage","score":0.7940000295639038},{"id":"https://openalex.org/keywords/anchorage-independent-growth","display_name":"anchorage-independent growth","score":0.875},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.8050000071525574},{"id":"https://openalex.org/keywords/cell-motility","display_name":"cell motility","score":0.718999981880188},{"id":"https://openalex.org/keywords/s-phase-progression","display_name":"S phase progression","score":0.7649999856948853},{"id":"https://openalex.org/keywords/timing-of-drug-administration","display_name":"timing of drug administration","score":0.6169999837875366},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6516218185424805},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.566752552986145},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5069899559020996},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5054123401641846},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.503684937953949},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4754445552825928},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.463407039642334},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.44272780418395996},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41252946853637695},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.4055802524089813},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3421974778175354},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3417876064777374},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2721940279006958},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2254895567893982},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2147584855556488},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.20662394165992737},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2008219063282013},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15285003185272217},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs-09-6110","doi":"https://doi.org/10.1158/0008-5472.sabcs-09-6110","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs-09-6110","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2075846474","https://openalex.org/W2166763732","https://openalex.org/W2165136032","https://openalex.org/W2278056998","https://openalex.org/W2117787937","https://openalex.org/W3130092584","https://openalex.org/W2159569733","https://openalex.org/W1986331836","https://openalex.org/W2089089032","https://openalex.org/W2465259064"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"type-I":[2],"insulin":[3,92,112],"like":[4],"growth":[5,194],"factor":[6],"(IGF-IR)":[7],"is":[8,220],"either":[9],"activated":[10],"and/or":[11],"overexpressed":[12],"in":[13,36,48,99,122,170,195,216,225,246],"a":[14,81],"wide":[15],"range":[16],"of":[17,31,66,115,214,253,261],"tumor":[18,255],"types":[19],"and":[20,27,91,97,101,111,119,144,198,258],"contributes":[21],"to":[22,75,250,267],"tumorigenicity,":[23],"proliferation,":[24],"survival,":[25],"metastasis":[26],"drug":[28],"resistance.":[29],"Disruption":[30],"IGF-IR":[32,84,90,236,262],"signaling":[33],"alone":[34,244],"or":[35,185,245],"combination":[37,226,247],"with":[38,59,157,182,204,227,248],"other":[39],"cytotoxic":[40],"agents":[41],"has":[42,53],"emerged":[43],"as":[44,222],"an":[45],"important":[46],"strategy":[47],"cancer":[49],"therapy.":[50],"Our":[51],"laboratory":[52],"shown":[54],"that":[55,80,128,179,234],"sequentially":[56],"combining":[57,180],"doxorubicin":[58,158,183,186,208,215],"anti-IGF-IR":[60,223],"antibodies":[61,224],"significantly":[62,159,190],"enhances":[63],"the":[64,69,133,192,212,235,259],"response":[65],"chemotherapy,":[67],"while":[68],"opposite":[70],"sequence":[71],"causes":[72],"cells":[73],"resistant":[74],"chemotherapy.":[76],"Here,":[77],"we":[78],"show":[79],"novel":[82],"small-molecule":[83],"kinase":[85,95,118,238],"inhibitor,":[86],"cis-3-[3-(4-methyl-piperazin-l-yl)-cyclobutyl]-1-(2-phenyl-quinolin-7-yl)-imidazo[1,5-a]pyrazin-8-ylamine":[87],"(PQIP)":[88],"inhibited":[89,129,136,191],"receptor":[93],"(IR)":[94],"activity":[96],"proliferation":[98],"MCF-7":[100,197],"MDA435/LCC6":[102,199],"cell":[103,124,131,137,172,256],"lines.":[104,125],"Moreover,":[105],"PQIP":[106,156,181,189,205,240],"treatment":[107],"blocked":[108,139],"both":[109,123,196],"IGF-I":[110,140],"stimulated":[113,141],"activation":[114],"mitogen-activated":[116],"protein":[117],"phosphatidylinositol":[120],"3-kinase":[121],"At":[126],"doses":[127],"monolayer":[130,171],"growth,":[132,218],"compound":[134],"also":[135,151],"motility,":[138],"S-phase":[142],"progression":[143],"induced":[145],"autophage;":[146],"at":[147],"higher":[148],"doses,":[149],"it":[150],"caused":[152],"PARP":[153,168],"cleavage.":[154],"Combining":[155],"enhanced":[160],"cytotoxicity":[161,213,252],"but":[162],"did":[163,209],"not":[164,210],"further":[165],"enhance":[166,211,251],"doxorubicin-induced":[167],"cleavage":[169],"growth.":[173],"Furthermore,":[174],"our":[175],"sequencing":[176],"studies":[177],"showed":[178],"simultaneously":[184],"followed":[187,206],"by":[188,207],"anchorage-independent":[193,217],"cells.":[200],"In":[201,229],"contrast,":[202],"pre-treatment":[203],"which":[219],"similar":[221],"doxorubicin.":[228,268],"summary,":[230],"these":[231],"results":[232],"suggest":[233],"tyrosine":[237],"inhibitor":[239],"can":[241],"be":[242],"used":[243],"chemotherapy":[249],"human":[254],"lines,":[257],"timing":[260],"inhibition":[263],"may":[264],"affect":[265],"responses":[266],"Citation":[269],"Information:":[270],"Cancer":[271],"Res":[272],"2009;69(24":[273],"Suppl):Abstract":[274],"nr":[275],"6110.":[276]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}